Whistleblower lawsuit accuses GSK of hiding Zantac's cancer risks and violating the federal False Claims Act.
GSK is facing a whistleblower lawsuit from Valisure, an independent Connecticut lab, which alleges that GSK hid Zantac's cancer risks for decades. The lawsuit claims that GSK violated the federal False Claims Act by not disclosing the risks while Medicare, Medicaid, and other health programs covered billions of dollars of prescriptions. If successful, the lawsuit could cost GSK billions of dollars in damages, including civil fines.
May 20, 2024
12 Articles